UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Molecular oncology, 2019-12, Vol.13 (12), p.2515-2530

2019

Link zum Volltext

Verfügbarkeit prüfen

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

Molecular oncology, 2018-01, Vol.12 (1), p.21-32

2018

Link zum Volltext

Verfügbarkeit prüfen

Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review

Lung cancer (Amsterdam, Netherlands), 2019-09, Vol.135, p.29-32

2019

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer

Cancer letters, 2010-02, Vol.288 (1), p.99-106

2010

Link zum Volltext

Verfügbarkeit prüfen

Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis

The lancet oncology, 2019-03, Vol.20 (3), p.361-370

2019

Link zum Volltext

Verfügbarkeit prüfen

PIK 3 CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Molecular oncology, 2019-12, Vol.13 (12), p.2515-2530

2019

Link zum Volltext

Verfügbarkeit prüfen

Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1year: a systematic review and meta-analysis

The lancet oncology, 2019-01, Vol.20 (3), p.361-370

2019

Link zum Volltext

Verfügbarkeit prüfen

Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group

Clinical breast cancer, 2018-02, Vol.18 (1), p.88-94

2018

Link zum Volltext

Verfügbarkeit prüfen

Micrometastatic disease in breast cancer: Clinical implications

European journal of cancer (1990), 2008-12, Vol.44 (18), p.2726-2736

2008

Link zum Volltext

Verfügbarkeit prüfen

Detection of Circulating Cytokeratin-19 mRNA-Positive Cells in the Blood and the Mitotic Index of the Primary Tumor Have Independent Prognostic Value in Early Breast Cancer

Clinical breast cancer, 2014-12, Vol.14 (6), p.442-450

2014

Link zum Volltext

Verfügbarkeit prüfen

Lack of evidence for fracture prevention in early breast cancer bisphosphonate trials: A meta-analysis

Gynecologic oncology, 2010-04, Vol.117 (1), p.139-145

2010

Link zum Volltext

Verfügbarkeit prüfen

Fulvestrant in the treatment of advanced breast cancer: A systematic review and meta-analysis of randomized controlled trials

Critical reviews in oncology/hematology, 2010-03, Vol.73 (3), p.220-227

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of RASSF1A promoter methylation in operable breast cancer

Clinical biochemistry, 2009-07, Vol.42 (10), p.970-975

2009

Link zum Volltext

Verfügbarkeit prüfen

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR

Clinical biochemistry, 2006-09, Vol.39 (9), p.879-887

2006

Link zum Volltext

Verfügbarkeit prüfen

Micrometastatic disease in breast cancer : Clinical implications: Advances in Translational Research in Breast Cancer: Bridge to Future Therapies

European journal of cancer (1990), 2008, Vol.44 (18), p.2726-2736

2008

Link zum Volltext

Verfügbarkeit prüfen

Molecular Detection and Prognostic Value of Circulating Cytokeratin-19 Messenger RNA–Positive and HER2 Messenger RNA–Positive Cells in the Peripheral Blood of Women with Early-Stage Breast Cancer

Clinical breast cancer, 2007-12, Vol.7 (11), p.883-889

2007

Link zum Volltext

Verfügbarkeit prüfen

High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study

Lung cancer (Amsterdam, Netherlands), 2004-06, Vol.44 (3), p.363-368

2004

Link zum Volltext

Verfügbarkeit prüfen

HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization

Clinical biochemistry, 2006-09, Vol.39 (9), p.942-946

2006

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective Analysis of Second-Line Chemotherapy or Best Supportive Care in Patients with Advanced-Stage Non–Small-Cell Lung Cancer

Clinical lung cancer, 2006-07, Vol.8 (1), p.49-55

2006

Link zum Volltext

Verfügbarkeit prüfen

Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group

Clinical lung cancer, 2005-11, Vol.7 (3), p.183-189

2005

Link zum Volltext

Verfügbarkeit prüfen

In vitro proliferative and differentiating characteristics of CD133 + and CD34 + cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO) : Potential implications for hematopoietic cell transplantation

Leukemia research, 2003-12, Vol.27 (12), p.1143-1151

2003

Link zum Volltext

Verfügbarkeit prüfen

In vitro proliferative and differentiating characteristics of CD133+ and CD34+ cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO)

Leukemia research, 2003-12, Vol.27 (12), p.1143-1151

2003

Link zum Volltext

Verfügbarkeit prüfen

One-year outcomes following a hypertensive urgency or emergency

European journal of internal medicine, 2024-02, Vol.120, p.107-113

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaPulmonary/respiratory

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(17)
Oncology
(14)
Female
(13)
Breast Cancer
(9)
Adult
(8)
Aged
(8)
Middle Aged
(8)
Hematology, Oncology And Palliative Medicine
(6)
Prognosis
(6)
Breast Neoplasms - Pathology
(5)
Circulating Tumor Cells
(5)
Biological And Medical Sciences
(4)
Breast Neoplasms - Blood
(4)
Breast Neoplasms - Drug Therapy
(4)
Breast Neoplasms - Genetics
(4)
Medical Sciences
(4)
Neoplasm Staging
(4)
Neoplastic Cells, Circulating - Pathology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer

Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis

PIK 3 CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1year: a systematic review and meta-analysis

Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group

Micrometastatic disease in breast cancer: Clinical implications

Detection of Circulating Cytokeratin-19 mRNA-Positive Cells in the Blood and the Mitotic Index of the Primary Tumor Have Independent Prognostic Value in Early Breast Cancer

Lack of evidence for fracture prevention in early breast cancer bisphosphonate trials: A meta-analysis

Fulvestrant in the treatment of advanced breast cancer: A systematic review and meta-analysis of randomized controlled trials

Prognostic significance of RASSF1A promoter methylation in operable breast cancer

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR

Micrometastatic disease in breast cancer : Clinical implications: Advances in Translational Research in Breast Cancer: Bridge to Future Therapies

Molecular Detection and Prognostic Value of Circulating Cytokeratin-19 Messenger RNA–Positive and HER2 Messenger RNA–Positive Cells in the Peripheral Blood of Women with Early-Stage Breast Cancer

High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study

HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization

A Retrospective Analysis of Second-Line Chemotherapy or Best Supportive Care in Patients with Advanced-Stage Non–Small-Cell Lung Cancer

Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group

In vitro proliferative and differentiating characteristics of CD133 + and CD34 + cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO) : Potential implications for hematopoietic cell transplantation

In vitro proliferative and differentiating characteristics of CD133+ and CD34+ cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO)

One-year outcomes following a hypertensive urgency or emergency

Aktive Filter

Suchergebnisse filtern